<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="letter" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title-group>
<journal-title>Brain</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32227164</article-id>
<article-id pub-id-type="pmc">7174030</article-id>
<article-id pub-id-type="doi">10.1093/brain/awaa070</article-id>
<article-id pub-id-type="publisher-id">awaa070</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>RSRC1</italic> loss-of-function variants cause mild to moderate autosomal recessive intellectual disability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2194-7239</contrib-id>
<name>
<surname>Scala</surname>
<given-names>Marcello</given-names>
</name>
<xref ref-type="corresp" rid="awaa070-cor1"></xref>
<xref ref-type="aff" rid="awaa070-aff1">a1</xref>
<xref ref-type="aff" rid="awaa070-aff2">a2</xref>
<xref ref-type="aff" rid="awaa070-aff3">a3</xref>
<!--<email>r.maroofian@ucl.ac.uk</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mojarrad</surname>
<given-names>Majid</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff4">a4</xref>
<xref ref-type="aff" rid="awaa070-aff5">a5</xref>
<xref ref-type="aff" rid="awaa070-aff6">a6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riazuddin</surname>
<given-names>Saima</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff7">a7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brigatti</surname>
<given-names>Karlla W</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff8">a8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ammous</surname>
<given-names>Zineb</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff9">a9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cohen</surname>
<given-names>Julie S</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff10">a10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hosny</surname>
<given-names>Heba</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff11">a11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Usmani</surname>
<given-names>Muhammad A</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff7">a7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-1537-3195</contrib-id>
<name>
<surname>Shahzad</surname>
<given-names>Mohsin</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff12">a12</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6012-0192</contrib-id>
<name>
<surname>Riazuddin</surname>
<given-names>Sheikh</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff12">a12</xref>
<xref ref-type="aff" rid="awaa070-aff13">a13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanley</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff14">a14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eslahi</surname>
<given-names>Atiye</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff4">a4</xref>
<xref ref-type="aff" rid="awaa070-aff15">a15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Person</surname>
<given-names>Richard E</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff16">a16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elbendary</surname>
<given-names>Hasnaa M</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff17">a17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Comi</surname>
<given-names>Anne M</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff10">a10</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-0358-2723</contrib-id>
<name>
<surname>Poskitt</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff8">a8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salpietro</surname>
<given-names>Vincenzo</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff1">a1</xref>
<xref ref-type="aff" rid="awaa070-aff2">a2</xref>
<xref ref-type="aff" rid="awaa070-aff3">a3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Genomics</surname>
<given-names>Queen Square</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff1">a1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>Jill A</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff18">a18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Katie B</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff19">a19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2233-3423</contrib-id>
<name>
<surname>Marafi</surname>
<given-names>Dana</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff18">a18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xia</surname>
<given-names>Fan</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff18">a18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Biderman Waberski</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff20">a20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zaki</surname>
<given-names>Maha S</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff17">a17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gleeson</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff14">a14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Puffenberger</surname>
<given-names>Erik</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff8">a8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-2866-7777</contrib-id>
<name>
<surname>Houlden</surname>
<given-names>Henry</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff1">a1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maroofian</surname>
<given-names>Reza</given-names>
</name>
<xref ref-type="aff" rid="awaa070-aff1">a1</xref>
</contrib>
</contrib-group>
<aff id="awaa070-aff1"><label>a1</label>
<institution>UCL Queen Square Institute of Neurology, University College London</institution>, London, <country country="GB">UK</country></aff>
<aff id="awaa070-aff2"><label>a2</label>
<institution>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa</institution>, Genoa, <country country="IT">Italy</country></aff>
<aff id="awaa070-aff3"><label>a3</label>
<institution>Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto Giannina Gaslini</institution>, Genoa, <country country="IT">Italy</country></aff>
<aff id="awaa070-aff4"><label>a4</label>
<institution>Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences</institution>, Mashhad, <country country="IR">Iran</country></aff>
<aff id="awaa070-aff5"><label>a5</label>
<institution>Medical Genetics Research Center, Mashhad University of Medical Sciences</institution>, Mashhad, <country country="IR">Iran</country></aff>
<aff id="awaa070-aff6"><label>a6</label>
<institution>Genetic Center of Khorasan Razavi</institution>, Mashhad, <country country="IR">Iran</country></aff>
<aff id="awaa070-aff7"><label>a7</label>
<institution>Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, University of Maryland</institution>, Baltimore, MD 21201, <country country="US">USA</country></aff>
<aff id="awaa070-aff8"><label>a8</label>
<institution>Clinic for Special Children</institution>, Strasburg, PA, <country country="US">USA</country></aff>
<aff id="awaa070-aff9"><label>a9</label>
<institution>Community Health Clinic</institution>, Topeka, IN, <country country="US">USA</country></aff>
<aff id="awaa070-aff10"><label>a10</label>
<institution>Departments of Neurology and Pediatrics, Kennedy Krieger Institute</institution>, Johns Hopkins Medical Institutions, Baltimore, MD, <country country="US">USA</country></aff>
<aff id="awaa070-aff11"><label>a11</label>
<institution>National Institute of Neuromotor System</institution>, Cairo, <country country="EG">Egypt</country></aff>
<aff id="awaa070-aff12"><label>a12</label>
<institution>Center for Genetic Diseases, Shaheed Zulfiqar Ali Bhutto Medical University, Pakistan Institute of Medical Sciences</institution>, Islamabad, <country country="PK">Pakistan</country></aff>
<aff id="awaa070-aff13"><label>a13</label>
<institution>National Centre of Excellence in Molecular Biology, University of the Punjab</institution>, Lahore 53700, <country country="PK">Pakistan</country></aff>
<aff id="awaa070-aff14"><label>a14</label>
<institution>Department of Neuroscience, Rady Children’s Institute for Genomic Medicine, Howard Hughes Medical Institute, University of California</institution>, San Diego, CA, <country country="US">USA</country></aff>
<aff id="awaa070-aff15"><label>a15</label>
<institution>Medical Genetics Research Center, Faculty of Medicine, Mashhad University of Medical Sciences</institution>, Mashhad, <country country="IR">Iran</country></aff>
<aff id="awaa070-aff16"><label>a16</label>
<institution>GeneDx</institution>, Gaithersburg, Maryland, <country country="US">USA</country></aff>
<aff id="awaa070-aff17"><label>a17</label>
<institution>Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre</institution>, Cairo 12311, <country country="EG">Egypt</country></aff>
<aff id="awaa070-aff18"><label>a18</label>
<institution>Department of Molecular and Human Genetics, Baylor College of Medicine</institution>, Houston, TX, <country country="US">USA</country></aff>
<aff id="awaa070-aff19"><label>a19</label>
<institution>Department of Pediatrics, University of Wisconsin Hospitals and Clinics</institution>, Madison, WI, <country country="US">USA</country></aff>
<aff id="awaa070-aff20"><label>a20</label>
<institution>Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health</institution>, Bethesda, Maryland, <country country="US">USA</country></aff>
<author-notes>
<corresp id="awaa070-cor1">Correspondence to: Reza Maroofian Queen Square Institute of Neurology University College of London Queen Square, WC1N 3BG, London, UK E-mail: <email>r.maroofian@ucl.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date iso-8601-date="2020-03-30" pub-type="epub">
<day>30</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>3</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>143</volume>
<issue>4</issue>
<fpage>e31</fpage>
<lpage>e31</lpage>
<permissions>
<copyright-statement>© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. </copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="awaa070.pdf"></self-uri>
<funding-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>University of Maryland</institution>
<institution-id institution-id-type="DOI">10.13039/100008510</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>National Institute of Neurological Disorders and Stroke</institution>
<institution-id institution-id-type="DOI">10.13039/100000065</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>NINDS</institution>
<institution-id institution-id-type="DOI">10.13039/100000065</institution-id>
</institution-wrap>
</funding-source>
<award-id>R01NS107428</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Medical Research Council</institution>
<institution-id institution-id-type="DOI">10.13039/501100000265</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>MRC</institution>
<institution-id institution-id-type="DOI">10.13039/501100000265</institution-id>
</institution-wrap>
</funding-source>
<award-id>MR/S01165X/1</award-id>
<award-id>MR/S005021/1</award-id>
<award-id>G0601943</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>The National Institute for Health Research University College London Hospitals Biomedical Research Centre</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Multiple System Atrophy Trust</institution>
<institution-id institution-id-type="DOI">10.13039/100013128</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Brain Research UK</institution>
<institution-id institution-id-type="DOI">10.13039/100013790</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Sparks Great Ormond Street Hospital Charity, Muscular Dystrophy</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Muscular Dystrophy Association</institution>
<institution-id institution-id-type="DOI">10.13039/100005202</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
<body>
<p>Sir,</p>
<p>We read with great interest the article by <xref ref-type="bibr" rid="awaa070-B8">Perez <italic>et al.</italic> (2018)</xref> on the emerging condition of intellectual disability caused by biallelic pathogenic variants in <italic>RSRC1</italic> (arginine and serine rich coiled-coil 1). Previous genome wide association studies (GWAS) by <xref ref-type="bibr" rid="awaa070-B10">Potkin <italic>et al.</italic> (2009</xref>, <xref ref-type="bibr" rid="awaa070-B9">2010</xref>) had suggested a possible involvement of <italic>RSRC1</italic> in non-syndromic intellectual disability and gene regulatory networks in schizophrenia. However, the results of these studies remained elusive and were not confirmed by a subsequent GWAS study by <xref ref-type="bibr" rid="awaa070-B22639237">Schizophrenia Working Group of the Psychiatric Genomics Consortium (</xref><xref ref-type="bibr" rid="awaa070-B22639237">2014</xref>). Meanwhile, <xref ref-type="bibr" rid="awaa070-B1">Berndt <italic>et al.</italic> (2013)</xref> identified <italic>RSRC1</italic> as a new locus influencing height through a genome-wide meta-analysis. The first family in which a homozygous <italic>RSRC1</italic> variant clearly segregated with non-syndromic intellectual disability was only recently reported by <xref ref-type="bibr" rid="awaa070-B5">Maddirevula <italic>et al.</italic> (2018)</xref>. A possible role of <italic>RSRC1</italic> in major depressive disorder has been further suggested by a meta-analysis on three large GWAS performed by <xref ref-type="bibr" rid="awaa070-B4">Li <italic>et al.</italic> (2018</xref>).</p>
<p>Serine and arginine-rich (SR) proteins are evolutionary conserved co-regulators of constitutive and alternative pre-mRNA splicing. The longest <italic>RSRC1</italic> transcript (NM_001271838.1) includes 10 exons (<xref ref-type="fig" rid="awaa070-F1">Fig. 1A</xref>) and encodes a 334-amino-acid SR-related protein of 53 kDa (SRrp53) (<xref ref-type="fig" rid="awaa070-F1">Fig. 1B</xref>), localized to the nuclear speckled domain. Interacting with other splicing regulators, RSRC1 plays a relevant role in the second step of pre-mRNA splicing. In addition, it could be involved in post-splicing mRNA processing, shuttling between the nucleus and cytoplasm (<xref ref-type="bibr" rid="awaa070-B2">Cazalla <italic>et al.</italic>, 2005</xref>). RSRC1 further promotes PIAS1-mediated SUMOylation of the pleiotropic transcription factor oestrogen receptor b (ERb), acting as transcriptional regulator (<xref ref-type="bibr" rid="awaa070-B3">Chen <italic>et al.</italic>, 2015</xref>).
</p>
<fig id="awaa070-F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>
<bold>Genetic findings and clinical pictures of <italic>RSRC1</italic> patients.</bold> (<bold>A</bold>) Schematic diagram of the longer <italic>RSRC1</italic> transcript (NM_001271838.1) consisting of 2597 nucleotides in 10 exons. The deletions encompassing exons 2 and 9–10 are represented by diagonal green lines. Single nucleotide variants are shown in red (previously reported patients) or in green (this study). (<bold>B</bold>) The RSRC1 protein (NP_001258767.1) consists of 334 amino acids encompassing an RS domain rich in arginine (R) and serine (S) that mediates the interactions with other RS-rich proteins involved in splicing regulation (SF2/ASF and U2AF35) and a coiled coil domain required for RSRC1/ERβ interaction as well as the enhancement of ERβ SUMOylation. The residues K196 and K 230 are necessary for RSRC1 SUMOylation by SUMO1 and the E3 ligases PIAS1 and PIAS3. Pathogenic amino acid changes reported in previous papers and identified in this study are shown in red and green, respectively. (<bold>C</bold>) Sequential pictures from selected patients. Patients from the Amish family (Patients 1–3) show prominent forehead, deep set eyes, depressed nasal bridge, protruding ears, and overbite with drooling. Redundant skin is evident in Patient 1. The Persian patient (Patient 7) shows straight eyebrows with mild synophrys, deep set eyes, and protruding ears. In the first Pakistani family (Patients 8 and 9) dysmorphic features include straight eyebrows with mild medial flaring, deep set eyes, wide nasal base, short philtrum, uplifted earlobes, and prominent chin. Subjects from the second Pakistani family (Patients 12–14) also show straight eyebrows with mild synophrys and deep set eyes, in addition to protruding ears with uplifted lobes (Patient 14). Patients from the Egyptian family (Patients 15–17) show thick eyebrows with medial sparing, deep set eyes, and prominent columella. (<bold>D</bold>) Graphic illustrations of the most common clinical findings in <italic>RSRC1</italic> patients in our cohort: the bar graph shows the percent distribution of the cardinal features of <italic>RSRC1</italic>-related intellectual disability, with the grey lines representing not available data; the pie charts show the percentage distribution of developmental delay/intellectual disability and the different behavioural abnormalities observed in <italic>RSRC1</italic> patients. Gene transcript and protein details available at: <ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org">https://www.ensembl.org</ext-link> (RSRC1-215, transcript ID ENST00000611884.5), <ext-link ext-link-type="uri" xlink:href="https://www.nextprot.org">https://www.nextprot.org</ext-link> (NX_Q96IZ7), <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org">https://www.uniprot.org</ext-link> (Q96IZ7), <ext-link ext-link-type="uri" xlink:href="https://www.proteomicsdb.org">https://www.proteomicsdb.org</ext-link> (Q96IZ7). ADHD = attention deficit hyperactivity disorder; ASD = autism spectrum disorder; DD = developmental delay; ID = intellectual disability; N/A = not available; Pt = patient; SCT = sluggish cognitive tempo; TT = temper tantrums.</p>
</caption>
<graphic xlink:href="awaa070f1"></graphic>
</fig>
<p>The involvement of <italic>RSRC1</italic> in cancer was first suggested by the identification of the recurrent <italic>PTPLB</italic>-<italic>RSRC1</italic> in-frame gene fusion in nasopharyngeal carcinoma by <xref ref-type="bibr" rid="awaa070-B16">Valouev <italic>et al.</italic> (2014)</xref>. <xref ref-type="bibr" rid="awaa070-B15">Teplyuk <italic>et al.</italic> (2016)</xref> showed that <italic>RSRC1</italic> is a target gene of the microRNA‐10b (miR‐10b), an oncogenic microRNA that is highly expressed in glioblastoma and represents a candidate for the development of targeted therapies. More recently, several studies have implicated RSRC1 in cancer predisposition and progression. The <italic>RSRC1</italic> intronic polymorphism rs6441201 G &gt; A has been associated with neuroblastoma susceptibility (<xref ref-type="bibr" rid="awaa070-B6">McDaniel <italic>et al.</italic>, 2017</xref>; <xref ref-type="bibr" rid="awaa070-B14">Tang <italic>et al.</italic>, 2018</xref>). A possible role of RSRC1 in non-small-cell lung cancer tumorigenesis and progression has been hypothesized based on the data from RNA sequencing data of tumour-educated platelets (<xref ref-type="bibr" rid="awaa070-B12">Sheng <italic>et al.</italic>, 2018</xref>). RSRC1 has been also shown to suppress gastric cancer cell proliferation and migration through the regulation of PTEN expression, acting as tumour suppressor (<xref ref-type="bibr" rid="awaa070-B18">Yu <italic>et al.</italic>, 2019</xref>).</p>
<p>The first <italic>RSRC1</italic> pathogenic variant segregating with intellectual disability was reported by <xref ref-type="bibr" rid="awaa070-B5">Maddirevula <italic>et al.</italic> (2018)</xref> in three affected siblings from a consanguineous Malaysian family (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 3</xref>). The homozygous truncating variant c.268C&gt;T (p.Arg90*) (NM_001271838.1) resulted in a full loss of function, causing the natural knockout of the gene. All the reported patients showed developmental delay and variable degree of intellectual disability. One subject also suffered from febrile seizures. Brain MRI was normal in the 10-year-old male (Patient 1), whereas temporal lobe atrophy was found in his 4-year-old brother (Patient 2). No distinctive neurological features or facial dysmorphism were observed. More recently, <xref ref-type="bibr" rid="awaa070-B8">Perez <italic>et al.</italic> (2018)</xref> reported five further individuals from consanguineous Bedouin kindred with early developmental delay, intellectual disability, hypotonia, behavioural abnormalities, and mild facial dysmorphic features. Brain MRI was normal (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 3</xref>). Exome sequencing revealed the homozygous c.205C&gt;T (p.Arg69*) in <italic>RSRC1</italic> (NM_001271838.1) in all patients, a nonsense variant leading to nonsense-mediated mRNA decay. <italic>RSRC1</italic> knock-down SH-SY5Y cells showed impaired alternative splicing. Specific differential expression of genes associated with intellectual disability, hypotonia, schizophrenia, and dementia was also observed, supporting the pivotal role of <italic>RSRC1</italic> in transcriptional regulation (<xref ref-type="bibr" rid="awaa070-B8">Perez <italic>et al.</italic>, 2018</xref>).</p>
<p>We report 17 additional subjects from seven consanguineous families with intellectual disability, behavioural abnormalities, and facial dysmorphism, harbouring homozygous <italic>RSRC1</italic> loss-of-function variants (<xref ref-type="table" rid="awaa070-T1">Table 1</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>). The families were of different ancestries (European/Middle Eastern, Saudi, Egyptian, Old Order Amish, Pakistani, and Persian) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. 1</xref>). The collaboration among the involved study centres was managed through GeneMatcher (<xref ref-type="bibr" rid="awaa070-B13">Sobreira <italic>et al.</italic>, 2015</xref>). After informed consent was obtained from the parents, photographic material was collected and genetic testing through exome sequencing was performed. Genetic methods are provided in detail in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>. Trio-exome sequencing was conducted in Patient 10, the family quartet was sequenced for Patients 8 and 9, and proband-exome sequencing was performed in all the remaining individuals, followed by variants validation through Sanger sequencing. No relevant single nucleotide variant was identified in the siblings of Amish ancestry (Patients 1–4), who were further studied through comparative genomic hybridization (CGH) array. Five <italic>RSRC1</italic> sequence variants (including an intragenic duplication) and two partial deletions were identified.
</p>
<table-wrap id="awaa070-T1" orientation="portrait" position="float">
<label>Table I</label>
<caption>
<p>Summary of genetic findings and clinical features of <italic>RSRC1</italic> patients</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
</colgroup>
<thead align="left">
<tr>
<th align="left" colspan="1" rowspan="1">Family</th>
<th align="left" colspan="4" rowspan="1">Family I (Amish)</th>
<th align="left" colspan="3" rowspan="1">Family II (Persian)</th>
<th align="left" colspan="2" rowspan="1">Family III (Pakistani)</th>
<th align="left" colspan="1" rowspan="1">Family IV (Saudi)</th>
<th align="left" colspan="1" rowspan="1">Family V (EUR/ ME)</th>
<th align="left" colspan="3" rowspan="1">Family VI (Pakistani)</th>
<th align="left" colspan="3" rowspan="1">Family VII (Egyptian)</th>
<th align="left" colspan="1" rowspan="1">Maddirevula <italic>et al.</italic><xref ref-type="bibr" rid="awaa070-B5">2018  </xref> (Malaysian)</th>
<th align="left" colspan="1" rowspan="1">Perez <italic>et al.</italic><xref ref-type="bibr" rid="awaa070-B8">2018  </xref> (Bedouin)</th>
</tr>
<tr>
<th colspan="1" rowspan="1">Patient</th>
<th align="left" colspan="1" rowspan="1">1(II-2)</th>
<th align="left" colspan="1" rowspan="1">2(II-3)</th>
<th align="left" colspan="1" rowspan="1">3(II-4)</th>
<th align="left" colspan="1" rowspan="1">4(II-5)</th>
<th align="left" colspan="1" rowspan="1">5(II-3)</th>
<th align="left" colspan="1" rowspan="1">6(II-1)</th>
<th align="left" colspan="1" rowspan="1">7(II-2)</th>
<th align="left" colspan="1" rowspan="1">8(II-2)</th>
<th align="left" colspan="1" rowspan="1">9(II-1)</th>
<th align="left" colspan="1" rowspan="1">10(II-2)</th>
<th align="left" colspan="1" rowspan="1">11(II-1)</th>
<th align="left" colspan="1" rowspan="1">12(II-6)</th>
<th align="left" colspan="1" rowspan="1">13(II-4)</th>
<th align="left" colspan="1" rowspan="1">14(II-3)</th>
<th align="left" colspan="1" rowspan="1">15(II-5)</th>
<th align="left" colspan="1" rowspan="1">16 (II-8)</th>
<th align="left" colspan="1" rowspan="1">17(II-9)</th>
<th align="left" colspan="1" rowspan="1">3 patients</th>
<th align="left" colspan="1" rowspan="1">5 patients</th>
</tr>
</thead>
<tbody align="left">
<tr>
<td colspan="1" rowspan="1">Age/sex</td>
<td colspan="1" rowspan="1">3 y/F</td>
<td colspan="1" rowspan="1">6 y/M</td>
<td colspan="1" rowspan="1">5 y/M</td>
<td colspan="1" rowspan="1">11 mo/M</td>
<td colspan="1" rowspan="1">6 y/M</td>
<td colspan="1" rowspan="1">14 y/F</td>
<td colspan="1" rowspan="1">3 y/F</td>
<td colspan="1" rowspan="1">9 y/M</td>
<td colspan="1" rowspan="1">11 y/M</td>
<td colspan="1" rowspan="1">4 y/M</td>
<td colspan="1" rowspan="1">16 y/F</td>
<td colspan="1" rowspan="1">6 y/F</td>
<td colspan="1" rowspan="1">15 y/M</td>
<td colspan="1" rowspan="1">16 y/F</td>
<td colspan="1" rowspan="1">22 y/F</td>
<td colspan="1" rowspan="1">16 y/F</td>
<td colspan="1" rowspan="1">12 y/F</td>
<td colspan="1" rowspan="1">4–10 y/2M, 1F</td>
<td colspan="1" rowspan="1">0.5–8 y/3F, 2M</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Homozygous RSRC1 variants [NM_001271838.1]</td>
<td colspan="4" rowspan="1">c.158,256,914_158,338,237del<xref ref-type="table-fn" rid="tblfn2"><sup>a</sup></xref></td>
<td colspan="3" rowspan="1">c.784 C&gt;T (p.Gln262*)</td>
<td colspan="2" rowspan="1">c.157,839,811_ 157,840, 314del<xref ref-type="table-fn" rid="tblfn3"><sup>b</sup></xref></td>
<td colspan="1" rowspan="1">c.250 C&gt;T (p.Arg84*)</td>
<td colspan="1" rowspan="1">c.441_447dupAGAAAAG (p.Glu150Argfs*6)</td>
<td colspan="3" rowspan="1">c.532-1 G&gt;A</td>
<td colspan="3" rowspan="1">c.3G&gt;T(p.Met1?)</td>
<td colspan="1" rowspan="1">c.268C&gt;T (p.Arg90*)</td>
<td colspan="1" rowspan="1">c.205C&gt;T (p.Arg69*)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Consanguinity</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+ (3)</td>
<td colspan="1" rowspan="1">+ (5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Dysmorphic features</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">+ (5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Global DD/ID</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">+ (5)</td>
<td colspan="1" rowspan="1">+/++ (5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Speech delay</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">+ (1)</td>
<td colspan="1" rowspan="1">+ (4)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Behavioural abnormalities</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">ASD</td>
<td colspan="1" rowspan="1">ADHD, ASD</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">ASD</td>
<td colspan="1" rowspan="1">ASD</td>
<td colspan="1" rowspan="1">ASD</td>
<td colspan="1" rowspan="1">ADHD</td>
<td colspan="1" rowspan="1">ADHD</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">SCT</td>
<td colspan="1" rowspan="1">Agg</td>
<td colspan="1" rowspan="1">Agg</td>
<td colspan="1" rowspan="1">SCT</td>
<td colspan="1" rowspan="1">ASD</td>
<td colspan="1" rowspan="1">Agg</td>
<td colspan="1" rowspan="1">ASD</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">TT (4), ASD (1), ADHD (4)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hypotonia</td>
<td colspan="1" rowspan="1">+++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">++</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">+ (5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Movement disorders</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Gait ataxia</td>
<td colspan="1" rowspan="1">Gait ataxia</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Gait ataxia</td>
<td colspan="1" rowspan="1">Gait ataxia</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Truncal ataxia</td>
<td colspan="1" rowspan="1">Brady-kinesia, ataxic gait</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Fine motor impairment (4)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Seizures</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">FS, GTCS</td>
<td colspan="1" rowspan="1">FS</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">GTCS</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">FS, GTCS</td>
<td colspan="1" rowspan="1">FS, GTCS</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">FS</td>
<td colspan="1" rowspan="1">FS (1)</td>
<td colspan="1" rowspan="1">FS (5), epilepsy (1)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Musculo-skeletal abnormalities</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">PP, CV</td>
<td colspan="1" rowspan="1">PP, CV</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">PP</td>
<td colspan="1" rowspan="1">PP</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">PP, CV, short toes</td>
<td colspan="1" rowspan="1">PP, short fifth toes</td>
<td colspan="1" rowspan="1">CV, genu valgum</td>
<td colspan="1" rowspan="1">PP</td>
<td colspan="1" rowspan="1">PP</td>
<td colspan="1" rowspan="1">PP</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Foot deformities (2)</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Brain MRI</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">PSS</td>
<td colspan="1" rowspan="1">PSS</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">MCA</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">Left temporo- parietal atrophy</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">N</td>
<td colspan="1" rowspan="1">Temporal lobes atrophy (1)</td>
<td colspan="1" rowspan="1">N (5)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tblfn1">
<p>ADHD = attention deficit hyperactivity disorder; Agg = aggressive; ASD = autism spectrum disorder; CV = cubitus valgus; DD = developmental delay; EUR = European; FS = febrile seizures; GTCS = generalized tonic-clonic seizures; ID = intellectual disability (+, mild; ++, moderate); MCA = mild cerebral atrophy; ME = Middle Eastern; mo = months; N = normal; N/A = not available; PP = pes planus; PSS = prominent subarachnoid spaces; SCT = sluggish cognitive tempo; y = years.</p>
</fn>
<fn id="tblfn2">
<label>
<sup>a</sup>
</label>
<p>hg19; 81-kb deletion encompassing exons 9–10 of <italic>RSRC1</italic> and whole <italic>MLF1</italic>.</p>
</fn>
<fn id="tblfn3">
<label>
<sup>b</sup>
</label>
<p>hg19; 500-bp deletion encompassing exon 2 of <italic>RSRC1</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In all the enrolled subjects, global psychomotor developmental delay and mild-to-moderate intellectual disability were observed. Twelve patients were diagnosed with variable behavioural disorders (<xref ref-type="table" rid="awaa070-T1">Table 1</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>). Neurological examination revealed generalized hypotonia in all patients and five of them had a history of hypotonia at birth. Decreased deep tendon reflexes were found in six patients (35%). Five patients showed gait ataxia, which was associated with bradykinesia in Patient 11. Truncal ataxia was observed in Patient 10. Seizures occurred in six individuals (35%), including four cases of febrile seizures. Afebrile generalized tonic-clonic seizures in addition to febrile seizures were observed in Patients 7, 12, and 13. Patient 10 experienced three episodes of generalized tonic-clonic seizures before becoming seizure-free. His EEG showed occasional epileptiform discharges in the centrofrontal and in the left parietocentral regions during sleep. No recurrent epileptic phenotype or peculiar EEG features were recognizable in our cohort. Psychomotor regression was not observed in any case. The most common dysmorphic features were deep-set eyes, broad nasal base, and ogival palate (<xref ref-type="fig" rid="awaa070-F1">Fig. 1C</xref>). Associated congenital anomalies were extremely variable, ranging from simple pes planus to redundant skin. Other isolated clinical features included mitral valve prolapse, recurrent respiratory infections in the first year of life, and tracheomalacia. When available, brain MRI did not reveal any distinctive finding. Non-specific mild cerebral atrophy was observed in Patients 5 and 6, whereas enlargement of subarachnoid spaces was found in Patients 2 and 3. Delayed myelination, dysmorphic lateral ventricles, and unilateral focal polymicrogyria were observed in Patient 10.</p>
<p>In our cohort, we identified homozygous <italic>RSRC1</italic> variants or deletions leading to loss of function (<xref ref-type="table" rid="awaa070-T1">Table 1</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>). Variants’ nomenclatures are given with reference to the <italic>RSRC1</italic> transcript NM_001271838.1. The four Amish siblings (Patients 1–4) carried an 81-kb deletion encompassing exons 9–10 of <italic>RSRC1</italic> and the entire <italic>MLF1</italic> gene. Although <italic>MLF1</italic> is involved in haematopoiesis and leukemogenesis, a possible pathogenic role for this gene in some of the dysmorphic features and congenital anomalies in the Amish patients cannot be excluded (<xref ref-type="bibr" rid="awaa070-B17">Yoneda-Kato <italic>et al.</italic>, 1996</xref>; <xref ref-type="bibr" rid="awaa070-B7">Nakamae <italic>et al.</italic>, 2017</xref>). A second 500-bp deletion involving exon 2 of <italic>RSRC1</italic> was identified in the siblings from the Pakistani family (Patients 8 and 9). Both these rearrangements are novel and are not reported in ClinVar and DECIPHER databases (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>). The three patients from the second Pakistani family (Patients 12–14) carried the splicing variant c.532-1G&gt;A. This amino acid change is predicted to cause aberrant splicing through the alteration of the splice acceptor site at exon 6 of <italic>RSRC1</italic> (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 3</xref>). In the remaining families, homozygous stop-gain or start-loss variants were identified. The 16-year-old female of European ancestry (Patient 11) harboured the intragenic duplication c.441_447dupAGAAAAG (p.Glu150Argfs*6). The stop-gain variants c.784C&gt;T (p.Gln262*) and c.250C&gt;T (p.Arg84*) were identified in the siblings from the Persian (Patients 5–7) and Middle East (Patient 10) families, respectively. In the Egyptian family (Patients 15–17), the variant c.3G&gt;T (p.Met1?) causing a start loss and leading to full loss of function (null variant) was found.</p>
<p>All the variants fully segregated with the phenotype and were not found in the most common genome databases, including the Genome Aggregation Database (gnomAD), Iranome, Greater Middle East Variome Project (GME Variome), and our database of 10 000 in-house control exomes. The only exception was the splicing variant c.532-1G&gt;A, which was observed in heterozygous state in 3 of 166 052 in gnomAD (allele frequency 0.00001806). Furthermore, the start loss variant affecting the same nucleotide of the c.3G&gt;T (p.Met1?) variant observed in our Egyptian family is reported in heterozygous state in gnomAD (genomes allele frequency 0.00003186). However, neither variant has been reported in homozygous state in healthy individuals. The analysis of sequence conservation through Genomic Evolutionary Rate Profiling (GERP) score revealed good conservation of the affected residues and <italic>in silico</italic> prediction analysis through CADD score calculation revealed high-deleterious scores (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 3</xref>). All variants were predicted to be damaging or likely damaging by several bioinformatic tools (e.g. SIFT, MutationTaster, and Human Splice Finder) and were classified as pathogenic (class 5) or likely pathogenic (class 4) according to the American College of Medical Genetics and Genomics (ACMG) guidelines (<xref ref-type="bibr" rid="awaa070-B11">Richards <italic>et al.</italic>, 2015</xref>).</p>
<p>This study supports the idea that <italic>RSRC1</italic> pathogenic variants cause a non-syndromic disorder characterized by mild-to-moderate intellectual disability, generalized hypotonia, and variable neurological and behavioural features (<xref ref-type="fig" rid="awaa070-F1">Fig. 1D</xref>). Despite a few minor dysmorphic features being observed (especially deep-set eyes and broad nasal base), a consistent recurrent facial gestalt could not be recognized. Furthermore, the extremely variable associated non-neurological features were not suggestive of a syndromic condition. Even though seizures are common in <italic>RSRC1</italic> patients, most of them only suffer from febrile seizures, lacking a distinctive epileptic phenotype. Definite epileptic seizures were only diagnosed in Patient 12 and in a case reported by <xref ref-type="bibr" rid="awaa070-B8">Perez <italic>et al.</italic> (2018)</xref>. This patient suffered from focal seizures with impaired awareness occasionally progressing to tonic-clonic and was treated with valproic acid. Behavioural abnormalities are frequent, although extremely variable and ranging from attention deficit hyperactivity disorder (ADHD) to autism spectrum disorder (ASD) (<xref ref-type="fig" rid="awaa070-F1">Fig. 1D</xref>). Besides the non-specific neuroradiological abnormalities observed in our patients, bilateral symmetric temporal lobe atrophy has been described in a single case by <xref ref-type="bibr" rid="awaa070-B5">Maddirevula <italic>et al.</italic> (2018)</xref>. Even though further neuroimaging studies will be necessary, the limited data available support the lack of a peculiar neuroradiological phenotype. According to these observations, biallelic <italic>RSRC1</italic> variants should be considered the cause of a non-syndromic intellectual disability mainly associated with generalized hypotonia and behavioural disturbances. Facial dysmorphism and other minor clinical features have limited diagnostic relevance, likewise neuroimaging is of limited value.</p>
<p>Thanks to the remarkable advances in gene discovery achieved through exome sequencing, the large group of known genes causing non-syndromic intellectual disability is rapidly expanding with relevant impact on diagnosis and patient management. Our findings support the pathogenic role of biallelic loss-of-function <italic>RSRC1</italic> variants in autosomal recessive intellectual disability, in addition to contributing to the phenotypic delineation of this emerging condition. Global developmental delay, mild-to-moderate intellectual disability, behavioural abnormalities, and generalized hypotonia represent the cardinal features of <italic>RSRC1</italic>-related intellectual disability. Other neurological features may be less frequently observed, especially hyporeflexia and febrile seizures. Further studies will help clarify the possible role of neuroimaging in the diagnostic process. In conclusion, we suggest that the involvement of <italic>RSRC1</italic> should be considered in the differential diagnosis in intellectually disabled children with hypotonia and behavioural disturbances, and that <italic>RSRC1</italic> should be included in next generation sequencing (NGS) panels for intellectual disability.</p>
<sec sec-type="data-availability">
<title>Data availability</title>
<p>Data sharing is not applicable to this article, as no new data were created or analysed in this study.</p>
</sec>
<sec>
<title>Web resources</title>
<p>The following URLs were used for data presented herein:</p>
<p>ClinVar; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar">https://www.ncbi.nlm.nih.gov/clinvar</ext-link></p>
<p>Combined Annotation Dependent Depletion (CADD); <ext-link ext-link-type="uri" xlink:href="http://cadd.gs.washington.edu">http://cadd.gs.washington.edu</ext-link></p>
<p>DECIPHER; <ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk">https://decipher.sanger.ac.uk</ext-link></p>
<p>Ensembl; <ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org/index.html">https://www.ensembl.org/index.html</ext-link></p>
<p>Gene Cards; <ext-link ext-link-type="uri" xlink:href="http://www.genecards.org">http://www.genecards.org</ext-link></p>
<p>Gene Matcher; <ext-link ext-link-type="uri" xlink:href="http://www.genematcher.org">http://www.genematcher.org</ext-link></p>
<p>Genome Aggregation Database (GnomAD); <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org">http://gnomad.broadinstitute.org</ext-link></p>
<p>Greater Middle East (GME) Variome Project; <ext-link ext-link-type="uri" xlink:href="http://igm.ucsd.edu/gme/">http://igm.ucsd.edu/gme/</ext-link></p>
<p>Human Splice Finder; <ext-link ext-link-type="uri" xlink:href="http://www.umd.be/HSF">http://www.umd.be/HSF</ext-link></p>
<p>Iranome; <ext-link ext-link-type="uri" xlink:href="http://www.iranome.ir">http://www.iranome.ir</ext-link></p>
<p>Mutalyzer; <ext-link ext-link-type="uri" xlink:href="https://mutalyzer.nl">https://mutalyzer.nl</ext-link></p>
<p>Mutation Taster; <ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http://www.mutationtaster.org</ext-link></p>
<p>NeXtProt; <ext-link ext-link-type="uri" xlink:href="https://www.nextprot.org">https://www.nextprot.org</ext-link></p>
<p>Online Mendelian Inheritance in Man; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Omim">http://www.ncbi.nlm.nih.gov/Omim</ext-link></p>
<p>Proteomics DB; <ext-link ext-link-type="uri" xlink:href="https://www.proteomicsdb.org">https://www.proteomicsdb.org</ext-link></p>
<p>PubMed; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed">http://www.ncbi.nlm.nih.gov/pubmed</ext-link></p>
<p>RefSeq; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/refseq">https://www.ncbi.nlm.nih.gov/refseq</ext-link></p>
<p>SIFT; <ext-link ext-link-type="uri" xlink:href="https://sift.bii.a-star.edu.sg">https://sift.bii.a-star.edu.sg</ext-link></p>
<p>The 1000 Genomes Browser; <ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org/index.html">http://browser.1000genomes.org/index.html</ext-link></p>
<p>The Greater Middle East (GME) Variome Project; <ext-link ext-link-type="uri" xlink:href="http://igm.ucsd.edu/gme/index.php">http://igm.ucsd.edu/gme/index.php</ext-link></p>
<p>UniProt; <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org">https://www.uniprot.org</ext-link></p>
<p>UCSC Human Genome Database; <ext-link ext-link-type="uri" xlink:href="http://www.genome.ucsc.edu">http://www.genome.ucsc.edu</ext-link></p>
<p>Varsome; <ext-link ext-link-type="uri" xlink:href="https://varsome.com">https://varsome.com</ext-link></p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="sup1">
<label>awaa070_Supplementary_Data</label>
<media xlink:href="awaa070_supplementary_data.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="ack1">
<title>Acknowledgements</title>
<p>The authors would like to thank the patients’ families for their support and consent to the publication of this study. This research was conducted as part of the Queen Square Genomics group at University College London, supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.</p>
<sec>
<title>Funding</title>
<p>The work at University of Maryland, Baltimore, USA was supported by National Institute of Neurological Disorders and Stroke (NINDS) (R01NS107428) (to S.R.). This study was funded by the Medical Research Council (MRC) (MR/S01165X/1, MR/S005021/1, G0601943), The National Institute for Health Research University College London Hospitals Biomedical Research Centre, Rosetree Trust, Ataxia UK, Multiple System Atrophy Trust, Brain Research UK, Sparks Great Ormond Street Hospital Charity, Muscular Dystrophy UK (MDUK), Muscular Dystrophy Association (MDA USA).</p>
</sec>
<sec>
<title>Competing interests</title>
<p>J.C. is consultant to Invitae. R.E.P. is an employee of GeneDx, Inc. The Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing completed at Baylor Genetics.</p>
</sec>
</ack>
<ref-list id="ref1">
<title>References</title>
<ref id="awaa070-B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Berndt</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Gustafsson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mägi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ganna</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Feitosa</surname><given-names>MF</given-names></name></person-group>, <etal>et al</etal><article-title>Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture</article-title>. <source/>Nat Genet<year>2013</year>; <volume>45</volume>: <fpage>501</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">23563607</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cazalla</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cáceres</surname><given-names>JF.</given-names></name></person-group>
<article-title>A novel SR-related protein is required for the second step of Pre-mRNA splicing</article-title>. <source/>Mol Cell Biol<year>2005</year>; <volume>25</volume>: <fpage>2969</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">15798186</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>B</given-names></name></person-group>, <etal>et al</etal><article-title>RSRC1 SUMOylation enhances SUMOylation and inhibits transcriptional activity of estrogen receptor β</article-title>. <source/>FEBS Lett<year>2015</year>; <volume>589</volume>: <fpage>1476</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">25937118</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>McIntosh</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal><article-title>Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder</article-title>. <source/>Neuropsychopharmacology<year>2018</year>; <volume>43</volume>: <fpage>2146</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">29728651</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Maddirevula</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Al Zahrani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Anazi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Almureikhi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ben-Omran</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Abdel-Salam</surname><given-names>GMH</given-names></name></person-group>, <etal>et al</etal><article-title>GWAS signals revisited using human knockouts</article-title>. <source/>Genet Med<year>2018</year>; <volume>20</volume>: <fpage>64</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">28640246</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McDaniel</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Conkrite</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Capasso</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vaksman</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Oldridge</surname><given-names>DA</given-names></name></person-group>, <etal>et al</etal><article-title>Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma</article-title>. <source/>PLoS Genet<year>2017</year>; <volume>13</volume>: <fpage>e1006787</fpage>.<pub-id pub-id-type="pmid">28545128</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nakamae</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Yokoyama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yoneda-Kato</surname><given-names>N.</given-names></name></person-group>
<article-title>Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia</article-title>. <source/>Blood Adv<year>2017</year>; <volume>1</volume>: <fpage>1682</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">29296815</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perez</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Menascu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kadir</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Basha</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Shorer</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal><article-title><italic>RSRC1</italic> mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3</article-title>. <source/>Brain<year>2018</year>; <volume>141</volume>: <fpage>961</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">29522154</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Potkin</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Macciardi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Guffanti</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fallon</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>JA</given-names></name></person-group>, <etal>et al</etal><article-title>Identifying gene regulatory networks in schizophrenia</article-title>. <source/>Neuroimage<year>2010</year>; <volume>53</volume>: <fpage>839</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">20600988</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Potkin</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Fallon</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Lakatos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Keator</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Guffanti</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal><article-title>Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia</article-title>. <source/>Mol Psychiatry<year>2009</year>; <volume>14</volume>: <fpage>416</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">19065146</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aziz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bale</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bick</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gastier-Foster</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal><article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source/>Genet Med<year>2015</year>; <volume>17</volume>: <fpage>405</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B22639237">
<mixed-citation publication-type="journal">Schizophrenia Working Group of the Psychiatric Genomics Consortium. 
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source/>Nature 2014; <volume>511</volume>: <fpage>421</fpage>–<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="awaa070-B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name></person-group>
<article-title>Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer</article-title>. <source/>Ono Targets Ther<year>2018</year>; <volume>11</volume>: <fpage>8143</fpage>–<lpage>51</lpage>.</mixed-citation>
</ref>
<ref id="awaa070-B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sobreira</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Schiettecatte</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Valle</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hamosh</surname><given-names>A.</given-names></name></person-group>
<article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene</article-title>. <source/>Hum Mutat<year>2015</year>; <volume>36</volume>: <fpage>928</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">26220891</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>JH</given-names></name></person-group>, <etal>et al</etal><article-title>RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children</article-title>. <source/>Gene<year>2018</year>; <volume>662</volume>: <fpage>83</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">29653227</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Teplyuk</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Uhlmann</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Gabriely</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Volfovsky</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Teng</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal><article-title>Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic</article-title>. <source/>EMBO Mol Med<year>2016</year>; <volume>8</volume>: <fpage>268</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">26881967</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Valouev</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Varma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>QT</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal><article-title>Discovery of recurrent structural variants in nasopharyngeal carcinoma</article-title>. <source/>Genome Res<year>2014</year>; <volume>24</volume>: <fpage>300</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">24214394</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yoneda-Kato</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Look</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Kirstein</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Valentine</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Raimondi</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>KJ</given-names></name></person-group>, <etal>et al</etal><article-title>The t(3; 5)(q25.1; q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1</article-title>. <source/>Oncogene<year>1996</year>; <volume>12</volume>: <fpage>265</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">8570204</pub-id></mixed-citation>
</ref>
<ref id="awaa070-B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gautam</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Quan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name></person-group>
<article-title>RSRC1 suppresses gastric cancer cell proliferation and migration by regulating PTEN expression</article-title>. <source/>Mol Med Rep<year>2019</year>; <volume>20</volume>: <fpage>1747</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">31257492</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>